— Know what they know.
Not Investment Advice
Also trades as: MXCT.L (LSE) · $vol 0M

MXCT NASDAQ

MaxCyte, Inc.
1W: -2.8% 1M: +19.1% 3M: +43.4% YTD: -31.6% 1Y: -51.4% 3Y: -71.3%
$1.04
-0.02 (-1.89%)
 
Weekly Expected Move ±14.3%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Buy · Power 64 · $111.4M mcap · 99M float · 0.996% daily turnover · Short 14% of daily vol

📊 Key Metrics

TTM
$32M
Revenue
-14.3% YoY
$-39M
Net Income
+6.4% YoY
$-30M
Free Cash Flow
+10.5% YoY
73.2%
Gross Margin
-64.1%
Op. Margin
-49.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-20.7%
ROA-17.7%
ROIC-35.3%

Valuation

P/E-2.8
P/B0.7
EV/EBITDA0.3

Leverage

Debt/Equity0.10
Current Ratio8.30
Interest Cov.0.0x

Quality Scores

Piotroski F1/9
Altman Z-0.24
Beneish M-2.59

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms